Satyam Veean

Satyam Veean

Auto-generated profile, based on publicly available information

Satyam Veean

Department of Radiology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2016 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
WPWanwisa Promsote
Wanwisa Promsote
FPFolami Lamoke Powell
Folami Lamoke Powell
SVSatyam Veean
Satyam Veean
MTMenaka Thounaojam
Menaka Thounaojam
SMShanu Markand
Shanu Markand
PMPamela M. Martin
Pamela M. Martin
Aims: Sickle retinopathy (SR) is a major cause of blindness in sickle cell disease (SCD). The genetic mutation responsible for SCD is known, however; oxidative stress and inflammation also figure prominently in the development and progression of pathology. Development of therapies for SR is hampered by the lack of (a) animal models that accurately recapitulate human SR and (b) strategies for noninvasive yet effective retinal drug delivery. This study addressed both issues by validating the Townes humanized SCD mouse as a model of SR and demonstrating the efficacy of oral administration of the antioxidant fumaric acid ester monomethyl fumarate (MMF) in the disease. Results: In vivo ophthalmic imaging, electroretinography, and postmortem histological RNA and protein analyses were used to monitor retinal health and function in normal (HbAA) and sickle (HbSS) hemoglobin-producing mice over a one-year period and in additional HbAA and HbSS mice treated with MMF (15 mg/ml) for 5 months. Functional and morphological abnormalities and molecular hallmarks of oxidative stress/inflammation were evident early in HbSS retinas and increased in number and severity with age. Treatment with MMF, a known inducer of Nrf2, induced γ-globin expression and fetal hemoglobin production, improved hematological profiles, and ameliorated SR-related pathology. Innovation and Conclusion: United States Food and Drug Administration-approved formulations in which MMF is the primary bioactive ingredient are currently available to treat multiple sclerosis; such drugs may be effective for treatment of ocular and systemic complications of SCD, and given the pleiotropic effects, other nonsickle-related diseases in which oxidative stress, inflammation, and retinal vascular pathology figure prominently. Antioxid. Redox Signal. 25, 921–935.

5 October 2016 in Postgraduate Medical Journal
Verified
Journal Article
Closed access
PDF file
SVSatyam Veean
Satyam Veean
NTNancy Thakkar
Nancy Thakkar
SGSupriya Gupta
Supriya Gupta
JKJayanth Keshavamurthy
Jayanth Keshavamurthy

1 January 2017 in Lung India
Verified
Journal Article
Open access
SVSatyam Veean
Satyam Veean
AJAlana James
Alana James
JKJayanthH Keshavamurthy
JayanthH Keshavamurthy
GSGyanendra Sharma
Gyanendra Sharma
R 33 hours revealed improvement of right ventricular size and function. EKOS catheters are useful for administration of fibrinolytics in pulmonary embolism....

1 January 2018 in Lung India
Verified
Journal Article
Open access
PDF file
SVSatyam Veean
Satyam Veean
WNWilliam Nixon
William Nixon
JKJayanth Keshavamurthy
Jayanth Keshavamurthy
The egg and banana sign can be seen on chest computed tomography (CT) in patients with severe pulmonary arterial hypertension (PAH). It is identified by the presence of the pulmonary artery (PA) lateral to the aortic arch with the aortic arch being described as the banana and the PA as the egg.

1 December 2016 in Radiology Case Reports
Verified
Journal Article
Open access
SVSatyam Veean
Satyam Veean
NPNeil Patel
Neil Patel
DLDaniel Lee
Daniel Lee
HVHoang Vo
Hoang Vo
EREran Rotem
Eran Rotem
This is a case of a 66-year-old African American male with history of end stage renal disease due to polycystic disease and failed right kidney transplant. He presents with asymptomatic hematuria, and diagnostic angiography was performed which showed incidental anastomotic site pseudoaneurysm. Our patient had an unusual presentation of a pseudoaneurysm. Pseudoaneurysms associated with failed renal transplants are typically detected within weeks after transplantation and along with failure of the transplant. Our patient's anastomotic site pseudoaneurysm was detected 21 years after transplantation and 15 years after transplant failure. Rupture of a pseudoaneurysm can occur at anytime and treating it with a covered stent is a feasible option.

1 June 2017 in Applied Radiology
Verified
Journal Article
Open access
NPNeil Patel
Neil Patel
SVSatyam Veean
Satyam Veean
EREran Rotem
Eran Rotem
HVHoang Vo
Hoang Vo
Crossref makes research objects easy to find, cite, link, assess, and reuse. We’re a not-for-profit membership organization that exists to make scholarly communications better.